ArticleCancers2021

Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients.

Ning Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.